<p>A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors</p>-Reference-Cited by-同舟云学术

A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors

Published:2019-09 Issue: Volume:Volume 10 Page:95-105
ISSN:1179-2728
Container-title:Lung Cancer: Targets and Therapy
language:en
Short-container-title:LCTT

Author:

Nagasaka Misako^ORCID,Abdallah Nadine^ORCID,Crosby Marcus,Thummala Nithin,Patel Dhaval,Wozniak Antoinette J,Gadgeel Shirish,Abrams Judith,Sukari Ammar^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis;Strahlentherapie und Onkologie;2023-11-17

2. Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis;Clinical & Experimental Metastasis;2023-06-13

3. Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189;JTO Clinical and Research Reports;2022-11

4. The effect of tumor size and metastatic extent on the efficacy of first line pembrolizumab monotherapy in patients with high PD-L1 expressing advanced NSCLC tumors;Lung Cancer;2021-12

5. Lack of Association Between Radiographic Tumor Burden and Efficacy of Immune Checkpoint Inhibitors in Advanced Lung Cancer;The Oncologist;2020-03-31